News | Administration

CU kidney specialist named in insider trading case

After speaking with Bomback, a Massachusetts hedge fund manager invested $800,000 in the pharmaceutical company that manufactures the drug Bomback was studying.

By Shira Poliak • September 28, 2011 at 9:55 AM

Write with us:

Submit an op-ed >

Have a tip?

Send it to us here >

More In News

Student Life

Columbia opens dining halls to Barnard students over breaks after fall break suspension

BY Priyanshi Poddar and Aubrey Rogers · NOV 5

Student Life

Columbia College Student Council unanimously ratifies updated constitution mandating new transparency standards

BY Madeline Ngo and Ethan Bordoff · NOV 5

Student Life

CCSC and ESC announce at-large representatives, class of 2030 election results

BY Celine Chien · NOV 5

Student Life

‘A wave of hope’: Columbia students celebrate Democrats’ big wins in midterm elections

BY Simon Leton · NOV 5

Editor's Picks

Administration

Mnookin confronts campus access, Trump administration, transparency in first Spectator interview

BY Manuela Moreyra, Spencer Davis, and Emily Pickering · SEP 14

Academics

Columbia to expand Middle East coursework with fall rollout of SIPA undergraduate major, confidential proposals show

BY Matt Luo and Celine Chien · JUL 7

Administration

A dental school administrator helped Epstein’s girlfriend get into Columbia twice. As others depart, he remains.

BY Ushoshi Das · MAY 1

Student Life

Columbia antidiscrimination office investigated student for handing out flyers criticizing trustees

BY Spencer Davis · APR 23

Student Life

Shrouded in secrecy, Columbia scales back undergraduate expansion plans as backlash mounts

BY Matt Luo · MAR 7

Spectator announces 150th managing board

BY Shea Vance, Heather Chen, and Albert Tsai · DEC 10, 2025